Skip to content

Comparison of Magnesium sulphate and Dexmedetomidine for controlling heart rate and blood pressure changes during laryngoscopy and endotracheal intubation

Comparison of intravenous 50% Magnesium sulphate and Dexmedetomidine for attenuation of cardiovascular stress response during laryngoscopy and endotracheal intubation - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/05/111449
Enrollment
80
Registered
2026-05-29
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Intravenous Dexmedetomidine ( 1 microgram/kg ) made into 50ml Normal saline given over 10 minutes , 10 minutes before induction: Comparison of cardiovascular stress response while lar

Sponsors

Parul Institute of Medical Science and Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients belonging to ASA 1 and 2 Patients undergoing elective surgery under general anaesthesia requiring endotracheal intubation No known history of drug allergy and sensitivity or other from of reaction to drugs used during anaesthesia Patients who provide informed written consent to participate in the study

Exclusion criteria

Exclusion criteria: Patients with known hypersensitivity or contraindications to Dexmedetomidine or Magnesium Sulfate Patients with significant cardiovascular diseases such as uncontrolled hypertension, arrhythmias, ischemic heart disease or failure Patients with renal or hepatic impairment Patients on medications that may interact with Dexmedetomidine or Magnesium Sulfate ( like calcium channel blockers, beta blockers) Pregnant and lactating women Patients with difficult airway anticipated or history of difficult intubation Emergency surgeries or patients requiring rapid sequence induction Patients with morbidly obesity ( Body Mass Index more than 30kilogram/meter square )

Design outcomes

Primary

MeasureTime frame
Following parameters are measured to observe hemodynamic stability Heart rate Systolic blood pressure Diastolic blood pressure Mean arterial pressure SpO2 At before induction before intubation start of intubation 3 minutes after intubation 5 minutes after intubation 10 minutes after intubation 15 minutes after intubation Complications Timepoint: Following parameters are measured to observe hemodynamic stability Heart rate Systolic blood pressure Diastolic blood pressure Mean arterial pressure SpO2 At before induction before intubation start of intubation 3 minutes after intubation 5 minutes after intubation 10 minutes after intubation 15 minutes after intubation Complications

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Galchar Payal Parbatbhai

Parul Institute of Medical Science and Research

arun.rohit20405@paruluniversity.ac.in9033373292

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026